Georgiamune Inc. has appointed Mark Avagliano as Chief Business Officer to empower the company to meet pivotal milestones and ensure the progress of its earlier stage pipeline. With over two decades of biopharma industry experience, Avagliano brings extensive skills to lead corporate strategy, business development, and portfolio prioritization efforts.
Who to call at Georgiamune, and when
A new leader at Georgiamune brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Georgiamune raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Georgiamune, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Georgiamune
Location
Gaithersburg, Maryland, United States
About
Georgiamune Inc. is a clinical-stage science and discovery biotechnology company focused on reprogramming immune signaling pathways to redirect the immune system to fight diseases. Georgiamune has designed unique approaches to re-establish immune balance, and its scientific discoveries have led to pioneering immunotherapies targeting high unmet needs. The company's lead program, GIM-122, is a first-in-class, dual-functioning monoclonal antibody. GIM-122 is designed to overcome immune therapy resistance in cancer patients. In addition to its lead program, the company is advancing a pipeline of first-in-class therapies for cancer and autoimmune diseases.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Georgiamune changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
GaithersburgBiotechnologyHealth CareMedicalTherapeutics